Galapagos starts filgotinib trial triggering milestone
Galapagos N.V. EuronextGLPG; NASDAQGLPG said the first patient was dosed in the Phase III DIVERSITY study of filgotinib GS6034 to treat Crohn's disease triggering a $50 million milestone payment from
View ArticleInnovent Biologics Inc. Pharmaceuticals Healthcare Deals and Alliances...
SummaryInnovent Biologics Inc. Innovent Biologics is a biopharmaceutical company that discovers develops and manufactures monoclonal antibodies. The company's product portfolio include monoclonal...
View ArticleIntestinal cells stave off bacteria by purging
Though purging is not prescribed as often as it was centuries ago intestinal cells known as enterocytes frequently resort to this ageold remedy. Researchers from the Immune Response and Development in...
View ArticleTakeda gains reimbursement in Canada for Crohns disease drug
Canadians living with Crohn's disease CD the most common form of inflammatory bowel disease may soon
View ArticleGalapagos begins DIVERSITY Phase III study of filgotinib to treat Crohns disease
Belgiumbased clinicalstage biotechnology company Galapagos has begun its DIVERSITY Phase III study of filgotinib to treat Crohns disease CD.
View ArticleGlobal Crohns Disease CD Market 20152019 Prices from USD $3000
About CDCD is an ongoing condition that causes inflammation of the digestive tract or the GI tract. CD may also be named as ileitis granulomatous enteritis or colitis regional enteritis or terminal...
View ArticleAcibadem Saglik Hizmetleri ve Ticaret AS Pharmaceuticals Healthcare Deals and...
SummaryAcibadem Saglik Hizmetleri ve Ticaret AS Acibadem is a healthcare service provider that offers diagnosis and treatment services. The center offers aesthetic plastic and reconstructive surgery;...
View ArticleGlobal Digestive Health Food and Drinks Market 20162020 Prices from USD $2500
About Digestive Health Food and DrinksDigestive health food and drinks are products designed to ease the symptoms or discomfort associated with an overburdened digestive tract. These products improve...
View ArticleGlobal Inflammatory Bowel Disease Market 20152019 Prices from USD $3000
About Inflammatory Bowel Disease Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a...
View ArticleSignificant advancement in Supportive Care for Cancer Patients published in...
NORWOOD Mass. Nov. 29 2016 PRNewswire Entrinsic Health Solutions Inc. an innovative health sciences company today announced the publication of results from research at the University of Florida using...
View ArticleInfusion Express Launches National Rollout of Infusion Clinics with LowerCost...
KANSAS CITY Mo. Nov. 29 2016 PRNewswire Infusion Express a patientfocused alternative to hospital infusion centers is opening several new treatment centers as part of a national expansion advancing a...
View ArticleBestGrinder.net Launches Scholarship for Medical Marijuana Patients
Applicants must submit an essay about how medical marijuana has helped them with their medical condition. The submission deadline is April 5 2017 and the winner will be selected on April 20 2017.Dover...
View ArticleAutoimmune Diseases Market in the US 20152019 Prices from USD $2500
About Autoimmune DiseasesAutoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system...
View ArticleCrohn's disease linked to thyroid cancer risk
Crohns disease is associated with an increased risk for thyroid cancer according to the results of a casecontrol study. These two disorders could share common pathogenetic pathways the researchers wrote.
View ArticleArena Pharmaceuticals Announces Four Upcoming Presentations at the 2016...
SAN DIEGO Nov. 30 2016 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that four abstracts will be presented at the 2016 Advances in Inflammatory Bowel Diseases Crohn's &...
View ArticleLarry Nance Jr. Illuminates Invisible Illnesses For Crohn's & Colitis...
NEW YORK Nov. 30 2016 PRNewswireUSNewswire To help raise awareness of Crohn's disease and ulcerative colitis Larry Nance Jr. is sharing his story with the Crohn's & Colitis Foundation of...
View ArticleBRIEFAbbvie says investigational IL23 inhibitor Risankizumab receives Orphan...
Abbvie receives Orphan Drug Designation forinvestigational IL23 inhibitor Risankizumab from the U.S. Foodand Drug Administration for the treatment of pediatric patientswith Crohn's DiseaseSource text...
View ArticleAbbVie Receives Orphan Drug Designation for Investigational IL23 Inhibitor...
Orphan Drug Designation program provides orphan status to medications intended for the safe and effective treatment diagnosis or prevention of rare diseases1 Risankizumab is an investigational...
View ArticlePhivida Launches Premium CBD Extracts Beverages and Wholesale Hemp Oil
New whole plant hemp oil extracts and infusions made from 100 certified organic hemp containing natural cannabinoids.Los Angeles CA PRWEB November 30 2016 With the successful passing of legalization in...
View Article